81
71
Growth Score 81 in past quarter
-5 pts
Heat Score 71 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
830004
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.
- Shlomo Sadoun: Founder and CEO
About the Company
TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO). With this, TrioxBio can provide patients with better access to high-quality, cost-effective medicines in
key therapeutic areas.